AI In Pharma Global Market Opportunities And Strategies To 2032

Description

“AI In Pharma Market Opportunities and Strategies to 2032 ” from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global AI in pharma market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Where is the largest and fastest-growing market for AI in pharma? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? “The AI in pharma market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider AI in pharma market; and compares it with other markets.

The report covers the following chapters:

Introduction And Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by drug type and by application market.

Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.

Macro-Economic Scenario - The report provides an analysis of the impact of the Russia-Ukraine war, impact of the COVID-19 pandemic and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the AI in pharma market.

Global Market Size And Growth - Global historic (2017-2022) and forecast (2022-2027, 2032F) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast.

Regional Analysis - Historic (2017-2022) and forecast (2022-2027, 2032F) market values and growth and market share comparison by region and country.

Market Segmentation - Contains the market values (2017-2022) (2022-2027, 2032F) and analysis for each segment by technology, by drug type and by application in the market. Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region market.

Regional Market Size And Growth - Regional market size (2022), historic (2017-2022) and forecast (2022-2027, 2032F) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.

Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.

Key Mergers And Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.

Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.

Conclusions And Recommendations - This section includes recommendations for AI in pharma providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.

Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Technology: Context-Aware Processing; Natural Language Processing; Querying Method; Deep Learning
2) By Drug Type: Small Molecule; Large Molecules
3) By Application: Diagnosis; Clinical Trial Research; Drug Discovery; Research And Development; Epidemic Prediction
Companies Mentioned: Concerto HealthAI; Alphabet Inc; OWKIN; Nvidia Corporation and Path AI
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; AI in pharma indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1002

1 Executive Summary

1.1 AI In Pharma - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 AI In Pharma Market Definition And Segmentations
6.4 Market Segmentation By Technology
- 6.4.1 Context-Aware Processing
- 6.4.2 Natural Language Processing
- 6.4.3 Querying Method
- 6.4.4 Deep Learning
6.5 Market Segmentation By Drug Type
- 6.5.1 Small Molecule
- 6.5.2 Large Molecules
6.6 Market Segmentation By Application
- 6.6.1 Diagnosis
- 6.6.2 Clinical Trial Research
- 6.6.3 Drug Discovery
- 6.6.4 Research And Development
- 6.6.5 Epidemic Prediction

7 Major Market Trends

7.1 Introduction Of Generative AI In Pharma To Improve Medical Consultations
7.2 Use Of AI In Molecular Target Identification
7.3 Integration Of AI In Drug Screening Process To Accelerate Drug Development
7.4 Growing Investments To Develop New Product Solutions
7.5 Strategic Partnerships And Collaborations Among Market Players

8 AI In Pharma Market - Macro Economic Scenario

8.1 COVID-19 Impact On The AI In Pharma Market
8.2 Impact Of The War In Ukraine On The AI In Pharma Market
8.3 Impact Of High Inflation On The AI In Pharma Market

9 Global Market Size and Growth

9.1 Market Size
9.2 Historic Market Growth, 2017 - 2022, Value ($ Million)
- 9.2.1 Market Drivers 2017 - 2022
- 9.2.2 Market Restraints 2017 - 2022
9.3 Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
- 9.3.1 Market Drivers 2022 - 2027
- 9.3.2 Market Restraints 2022 - 2027

10 Global AI In Pharma Market Segmentation

10.1 Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
10.2 Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
10.3 Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)

11 AI In Pharma Market, Regional and Country Analysis

11.1 Global AI In Pharma Market, By Region, Historic and Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
11.2 Global AI In Pharma Market, By Country, Historic and Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)

12 Asia-Pacific Market

12.1 Summary
- 12.1.1 Market Overview
- 12.1.2 Region Information
- 12.1.3 Market Information
- 12.1.4 Background Information
- 12.1.5 Government Initiatives
- 12.1.6 Regulations
- 12.1.7 Regulatory Bodies
- 12.1.8 Major Associations
- 12.1.9 Taxes Levied
- 12.1.10 Corporate Tax Structure
- 12.1.11 Investments
- 12.1.12 Major Companies
12.2 Asia-Pacific AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.3 Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.4 Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.5 Asia-Pacific AI In Pharma Market: Country Analysis
12.6 China Market
12.7 Summary
- 12.7.1 Market Overview
- 12.7.2 Country Information
- 12.7.3 Market Information
- 12.7.4 Background Information
- 12.7.5 Government Initiatives
- 12.7.6 Regulations
- 12.7.7 Regulatory Bodies
- 12.7.8 Major Associations
- 12.7.9 Taxes Levied
- 12.7.10 Corporate Tax Structure
- 12.7.11 Investments
- 12.7.12 Major Companies
12.8 China AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.9 China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.10 China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.11 India Market
12.12 India AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.13 India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.14 India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.15 Japan Market
12.16 Japan AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.17 Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.18 Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.19 Australia Market
12.20 Australia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.21 Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.22 Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.25 Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.26 Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.29 South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12.30 South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)

13 Western Europe Market

13.1 Summary
- 13.1.1 Market Overview
- 13.1.2 Region Information
- 13.1.3 Market Information
- 13.1.4 Background Information
- 13.1.5 Government Initiatives
- 13.1.6 Regulations
- 13.1.7 Regulatory Bodies
- 13.1.8 Major Associations
- 13.1.9 Taxes Levied
- 13.1.10 Corporate Tax Structure
- 13.1.11 Investments
- 13.1.12 Major Companies
13.2 Western Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
13.3 Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
13.4 Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
13.5 Western Europe AI In Pharma Market: Country Analysis
13.6 UK Market
13.7 UK AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
13.8 UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
13.9 UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
13.10 Germany Market
13.11 Germany AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
13.12 Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
13.13 Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
13.14 France Market
13.15 France AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
13.16 France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
13.17 France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)

14 Eastern Europe Market

14.1 Summary
- 14.1.1 Market Overview
- 14.1.2 Region Information
- 14.1.3 Market Information
- 14.1.4 Background Information
- 14.1.5 Government Initiatives
- 14.1.6 Regulations
- 14.1.7 Regulatory Bodies
- 14.1.8 Major Associations
- 14.1.9 Taxes Levied
- 14.1.10 Corporate Tax Structure
- 14.1.11 Investments
- 14.1.12 Major Companies
14.2 Eastern Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
14.3 Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
14.4 Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
14.5 Eastern Europe AI In Pharma Market: Country Analysis
14.6 Russia Market
14.7 Russia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
14.8 Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
14.9 Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)

15 North America Market

15.1 Summary
- 15.1.1 Market Overview
- 15.1.2 Region Information
- 15.1.3 Market Information
- 15.1.4 Background Information
- 15.1.5 Government Initiatives
- 15.1.6 Regulations
- 15.1.7 Regulatory Bodies
- 15.1.8 Major Associations
- 15.1.9 Taxes Levied
- 15.1.10 Corporate Tax Structure
- 15.1.11 Investments
- 15.1.12 Major Companies
15.2 North America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
15.3 North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
15.4 North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
15.5 North America AI In Pharma Market: Country Analysis
15.6 USA Market
15.7 Summary
- 15.7.1 Country Information
- 15.7.2 Market Information
- 15.7.3 Background Information
- 15.7.4 Government Initiatives
- 15.7.5 Regulations
- 15.7.6 Regulatory Bodies
- 15.7.7 Major Associations
- 15.7.8 Taxes Levied
- 15.7.9 Corporate Tax Structure
- 15.7.10 Investments
- 15.7.11 Major Companies
15.8 USA AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
15.9 USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
15.10 USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)

16 South America Market

16.1 Summary
- 16.1.1 Market Overview
- 16.1.2 Region Information
- 16.1.3 Market Information
- 16.1.4 Background Information
- 16.1.5 Government Initiatives
- 16.1.6 Regulations
- 16.1.7 Regulatory Bodies
- 16.1.8 Major Associations
- 16.1.9 Taxes Levied
- 16.1.10 Corporate Tax Structure
- 16.1.11 Investments
- 16.1.12 Major Companies
16.2 South America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
16.3 South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
16.4 South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
16.5 South America AI In Pharma Market: Country Analysis
16.6 Brazil Market
16.7 Brazil AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
16.8 Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
16.9 Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)

17 Middle East Market

17.1 Summary
- 17.1.1 Market Overview
- 17.1.2 Region Information
- 17.1.3 Market Information
- 17.1.4 Background Information
- 17.1.5 Government Initiatives
- 17.1.6 Regulations
- 17.1.7 Regulatory Bodies
- 17.1.8 Major Associations
- 17.1.9 Taxes Levied
- 17.1.10 Corporate Tax Structure
- 17.1.11 Investments
- 17.1.12 Major Companies
17.2 Middle East AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
17.3 Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
17.4 Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)

18 Africa Market

18.1 Summary
- 18.1.1 Market Overview
- 18.1.2 Region Information
- 18.1.3 Market Information
- 18.1.4 Background Information
- 18.1.5 Government Initiatives
- 18.1.6 Regulations
- 18.1.7 Regulatory Bodies
- 18.1.8 Major Associations
- 18.1.9 Taxes Levied
- 18.1.10 Corporate Tax Structure
- 18.1.11 Investments
- 18.1.12 Major Companies
18.2 Africa AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
18.3 Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
18.4 Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)

19 Competitive Landscape And Company Profiles

19.1 Company Profiles
19.2 Concerto HealthAI
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Business Strategy
- 19.2.4 Financial Overview
19.3 Alphabet Inc.
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Business Strategy
- 19.3.4 Financial Overview
19.4 OWKIN
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Business Strategy
- 19.4.4 Financial Overview
19.5 Nvidia Corporation
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Business Strategy
- 19.5.4 Financial Overview
19.6 PathAI
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Business Strategy
- 19.6.4 Financial Overview

20 Key Mergers And Acquisitions

20.1 BioNTech Acquired InstaDeep
20.2 Recursion Pharmaceuticals Acquired Cyclica And Valence
20.3 Telix Pharmaceuticals Acquired Dedicaid GmbH
20.4 Envision Pharma Group Acquired OKRA.ai
20.5 Bayer AG Acquired Blackford Analysis Ltd
20.6 iBio Acquired Rubryc Therapeutics
20.7 Genentech Acquired Prescient Design
20.8 Nurosene Health Inc Acquired Netramark Incorporated
20.9 X-Chem Acquired Glamorous AI

21 Opportunities And Strategies

21.1 Global AI In Pharma Market In 2027 - Countries Offering Most New Opportunities
21.2 Global AI In Pharma Market In 2027 - Segments Offering Most New Opportunities
21.3 Global AI In Pharma Market In 2027 - Growth Strategies
- 21.3.1 Market Trend Based Strategies
- 21.3.2 Competitor Strategies

22 AI In Pharma Market, Conclusions And Recommendations

22.1 Conclusions
22.2 Recommendations
- 22.2.1 Product
- 22.2.2 Place
- 22.2.3 Price
- 22.2.4 Promotion
- 22.2.5 People

23 Appendix

23.1 Geographies Covered
23.2 Market Data Sources
23.3 Research Methodology
23.4 Currencies
23.5 The Business Research Company
23.6 Copyright and Disclaimer